Two-year follow-up after chelating therapy in a patient with adult-onset parkinsonism and hypermanganesaemia due to SLC30A10 mutations

J Neurol. 2014 Jan;261(1):227-8. doi: 10.1007/s00415-013-7187-5. Epub 2013 Nov 26.

Authors

L Di Toro Mammarella¹, A Mignarri, C Battisti, L Monti, V Bonifati, F Rasi, A Federico

Affiliation

¹ Department of Medicine, Surgery and Neuroscience, University of Siena, 53100, Siena, Italy, laraditorom@libero.it.

PMID: 24276520
DOI: 10.1007/s00415-013-7187-5

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cation Transport Proteins / genetics*
Chelation Therapy / methods*
Female
Humans
Longitudinal Studies
Metabolic Diseases / complications
Metabolic Diseases / genetics*
Middle Aged
Mutation / genetics*
Parkinsonian Disorders / complications
Parkinsonian Disorders / drug therapy*
Parkinsonian Disorders / genetics*
Zinc Transporter 8

Substances

Cation Transport Proteins
SLC30A8 protein, human
Zinc Transporter 8

Supplementary concepts

Hypermanganesemia with Dystonia Polycythemia and Cirrhosis